Orbital Inflammatory Disease
Not all orbital inflammation is caused by bacteria. Orbital inflammatory disease encompasses a spectrum of non-infectious conditions — from idiopathic orbital pseudotumor to IgG4-related disease to systemic vasculitides — that can look identical to orbital infection on initial presentation. Accurate diagnosis requires imaging, laboratory evaluation, and often tissue biopsy. Treatment with the wrong agent (antibiotics for pseudotumor, or steroids for lymphoma) delays care and can cause harm.
Overview
The differential diagnosis of orbital inflammation is broad. The major categories are:
Idiopathic (OIS)
No identifiable cause; responsive to steroids; must exclude lymphoma
See OIS section belowIgG4-Related
Fibro-inflammatory systemic disease; biopsy required; rituximab for refractory cases
See IgG4 section belowAutoimmune / Thyroid
Thyroid Eye Disease (Graves' orbitopathy) — the most common cause of proptosis
See TED page →Granulomatous
Sarcoidosis, GPA (Wegener's) — systemic disease with orbital involvement
See section belowNeoplastic (mimic)
Lymphoma, metastases — can resemble inflammatory disease; biopsy essential
See orbital tumors →Orbital Inflammatory Syndrome (OIS) — Orbital Pseudotumor
Orbital Inflammatory Syndrome (OIS), also called idiopathic orbital inflammation or the older term orbital pseudotumor, is the most common cause of painful unilateral proptosis in adults without an identifiable systemic cause. It is a diagnosis of exclusion — meaning infection, lymphoma, IgG4-disease, and other specific conditions must first be ruled out.
OIS can involve any orbital structure, and its subtype shapes the presentation:
Orbital fat inflammation (dacryoadenitis variant excluded)
Diffuse proptosis, pain; CT shows infiltration of orbital fat
Myositis
Diplopia, pain with gaze, enlarged extraocular muscle including the tendon — distinguishes it from TED (TED spares the tendon)
Dacryoadenitis
Painful lacrimal gland swelling; S-shaped upper lid; CT shows enlarged lacrimal gland
Scleritis / Posterior scleritis
Severe ocular pain, choroidal folds on fundus; ultrasound shows scleral thickening (T-sign)
Apical OIS / Tolosa-Hunt syndrome
Painful ophthalmoplegia from orbital apex inflammation; responds dramatically to steroids
Classic steroid response: OIS typically responds dramatically to systemic corticosteroids within 24–48 hours — a response so characteristic that it is sometimes used diagnostically. However, orbital lymphoma can also respond to steroids temporarily, making biopsy essential when the diagnosis is uncertain or the clinical picture is atypical.
Treatment: Oral prednisone 1 mg/kg/day, tapered over 4–6 weeks. Recurrence during taper is common; refractory cases are managed with methotrexate, mycophenolate mofetil, or low-dose orbital radiation. Biopsy is performed for atypical presentations, incomplete steroid response, or recurrence in the same location.
IgG4-Related Orbital Disease (IgG4-ROD)
IgG4-related disease (IgG4-RD) is a systemic fibro-inflammatory condition in which IgG4-secreting plasma cells infiltrate organs and stimulate fibroblasts to lay down dense collagen. The orbit — particularly the lacrimal gland — is among the most commonly involved sites. It was formerly classified under various names including Mikulicz’s disease, orbital lymphoid hyperplasia, and sclerosing orbital pseudotumor; IgG4-RD is now the unifying diagnosis for many of these conditions.
Clinical Features
- Painless bilateral lacrimal gland enlargement (most common)
- Slow onset — months to years
- Proptosis, diplopia, dry eye from lacrimal gland damage
- Systemic: salivary gland enlargement, autoimmune pancreatitis, aortitis
- Serum IgG4 elevated in ~70% — normal IgG4 does not exclude diagnosis
Diagnosis (Biopsy Required)
- Dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells
- IgG4:IgG ratio > 40%
- Storiform (whorling) fibrosis
- Obliterative phlebitis
- Must distinguish from orbital lymphoma — critical
Treatment: Systemic corticosteroids are first-line but relapse is very common on taper. Rituximab (anti-CD20 biologic) is effective for relapsing or refractory disease and may induce durable remission. Untreated IgG4-ROD leads to progressive fibrosis causing permanent dry eye, lacrimal gland atrophy, ptosis, and optic nerve compression.
Sarcoidosis & Granulomatosis with Polyangiitis (GPA)
Sarcoidosis
Sarcoidosis is a systemic granulomatous disease that can infiltrate the orbit, lacrimal gland, and optic nerve. Orbital sarcoidosis most commonly presents as bilateral, painless lacrimal gland enlargement — overlapping clinically with IgG4-ROD. Biopsy reveals non-caseating granulomas. Systemic manifestations (pulmonary hilar lymphadenopathy, skin lesions, elevated ACE) support the diagnosis. Treatment is corticosteroids; refractory cases may benefit from methotrexate or infliximab.
Granulomatosis with Polyangiitis (GPA)
GPA (formerly Wegener’s granulomatosis) is a small-vessel vasculitis affecting the upper and lower respiratory tract and kidneys. Orbital involvement — from sinus extension through the orbital wall — causes inflammatory proptosis, scleritis, and optic neuropathy. c-ANCA (PR3-ANCA) is positive in >90% of systemic GPA. Treatment requires systemic immunosuppression with rituximab or cyclophosphamide plus steroids; orbital surgery may be needed for decompression.
Thyroid Eye Disease — A Separate Page
Thyroid Eye Disease (TED / Graves’ orbitopathy) is the most common cause of adult proptosis and is technically an orbital inflammatory disease — driven by TSH-receptor antibodies that cause expansion of orbital fat and extraocular muscles. However, because of its distinct pathophysiology, biomarkers (TRAb, anti-TPO), treatment (Tepezza infusion, orbital decompression), and multidisciplinary management with endocrinology, TED is covered in detail on its own dedicated page.
Orbital Infections — Different Diagnosis, Different Treatment
Orbital cellulitis and abscess are bacterial infections requiring IV antibiotics and often urgent surgical drainage. They can look similar to OIS on initial presentation — fever, painful proptosis, restricted motility — but are managed completely differently. The detailed comparison of orbital infection vs. OIS, IgG4, and TED (including the clinical comparison table) is on the Infections page.
Orbital Infection vs. Inflammatory Disease — Comparison →Diagnosis & Biopsy
A systematic workup is essential for any orbital inflammatory presentation. The goal is to identify a specific diagnosis before committing to a treatment — particularly to distinguish treatable inflammatory conditions from lymphoma.
- Onset: acute (OIS, infection) vs. chronic (IgG4, sarcoid)
- Pain: painful (OIS, myositis, infection) vs. painless (IgG4, lymphoma)
- Thyroid disease history (TED)
- Systemic symptoms: sinusitis, joint pain, skin rash, dry mouth
- MRI orbit with fat suppression: best for soft-tissue characterization
- CT with contrast: first line for acute proptosis and sinus disease
- IgG4: bilateral lacrimal gland + infraorbital nerve involvement is characteristic
- TED: muscle belly enlargement with tendon sparing — the reverse of myositis
- TRAb, free T4, TSH (thyroid)
- Serum IgG4 and IgG subclasses
- c-ANCA/p-ANCA (GPA)
- ANA (lupus, RA)
- ACE, chest X-ray or CT (sarcoidosis)
- CBC and LDH (lymphoma screen)
- Required for: IgG4-ROD (definitive diagnosis), atypical OIS, any mass not explained by imaging and labs
- Lacrimal gland biopsy: relatively accessible; preferred site
- Open orbital biopsy: for posterior or deep lesions — performed by oculoplastic surgeon
- Fine needle aspiration biopsy (FNAB): useful for cytology in select cases
Treatment by Diagnosis
| Diagnosis | First-Line | Refractory / Chronic |
|---|---|---|
| OIS (pseudotumor) | Oral prednisone 1 mg/kg/day × 4–6 weeks, taper | Methotrexate, mycophenolate, orbital radiation |
| IgG4-ROD | Systemic corticosteroids | Rituximab (anti-CD20) — preferred; durable remission |
| Sarcoidosis | Systemic corticosteroids | Methotrexate, hydroxychloroquine, infliximab |
| GPA (Wegener's) | Rituximab + high-dose steroids | Cyclophosphamide; ENT for sinus disease |
| TED — active | Tepezza (teprotumumab) IV infusion × 8 doses | Orbital decompression, strabismus surgery, eyelid surgery |
| Orbital lymphoma | Oncology referral — rituximab ± CHOP for B-cell | Orbital radiation for localized MALToma |
Schedule an Orbital Consultation
Dr. Brown evaluates complex orbital conditions — including biopsy, steroid management coordination, and surgical decompression — at our Mobile and Daphne offices.